Gris-PEG (State of Florida DOH Central Pharmacy)


Welcome to the PulseAid listing for the Gris-PEG drug offered from State of Florida DOH Central Pharmacy. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: State of Florida DOH Central Pharmacy
NON-PROPRIETARY NAME: GRISEOFULVIN
SUBSTANCE NAME: GRISEOFULVIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Gris-PEG HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGris-PEG from State of Florida DOH Central Pharmacy
LABELER NAME: State of Florida DOH Central Pharmacy
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53808-0261_95cbdf47-932d-40d3-bc1d-e055170711d6
PRODUCT NDC: 53808-0261
APPLICATION NUMBER: NDA050475

Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Griseofulvin
Cipla USA Inc.grisofulvin
CorePharma, LLCUltramicrosize Griseofulvin
Oceanside PharmaceuticalsGriseofulvin
Pedinol Pharmacal, Inc.Gris-PEG
Physicians Total Care, Inc.Griseofulvin
Qualitest PharmaceuticalsGriseofulvin
Rebel Distributors CorpGriseofulviin (microsize)
RiconPharma LLC.Ultramicrosize Griseofulvin
Rising Pharmaceuticals Inc.Griseofulvin
Rising Pharmaceuticals, IncGriseofulvin
Sandoz IncGriseofulvin
State of Florida DOH Central PharmacyGris-PEG